Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Pfizer Biopharma JV To Go Public In $780M SPAC Union (<em>Law360</em>)

Pfizer Biopharma JV To Go Public In $780M SPAC Union (Law360)

Related Content

SEC Adopts Reforms Relating to Investment Advisers Operating Exclusively Through the Internet

At the Intersection of ‘S’ and ‘G’ of ESG: London Leading the Way on Board Diversity — An Update on Latest FTSE Women Leaders Review and Parker Review Reports

Agencies Extend Applicability Date of Certain Provisions of their CRA Final Rule

FinCEN Publishes an Administrative Ruling Regarding Customer Identification Program and Customer Due Diligence Requirements for Designated Beneficiaries of Individual Retirement Accounts

New SEC Climate Rules Stayed by Fifth Circuit – For Now

Federal Reserve Announces Final Rule Updating Risk Management Requirements for Certain Systemically Important Financial Market Utilities

CFPB Issues Guidance Regarding Comparison-Shopping Results for Credit Cards and Other Financial Products

OCC Amends FOIA Regulations

Goodwin Represents the Underwriters in PACS Group $450 Million IPO

Goodwin Advises Exclusive Placement Agent in Acrivon Therapeutics’ $130 Million Private Placement

Astera Labs Completes Upsized $774 Million Initial Public Offering

NAPCO Securities Technologies Completes $81.5 Million Secondary Offering

FogPharma Completes $145 Million Series E Financing

Absci Corporation Closes $86.4 Million Follow-On Offering

Goodwin Represents the Initial Purchasers and Dealers on Lyft, Inc.’s $460 million 0.625% Convertible Senior Notes Offering and Capped Call

Chambers Global 2024 Recognizes Goodwin Lawyers and Practices as Worldwide Leaders

Life Sciences

Private Equity

Capital Markets

Life Sciences IPOs & Capital Markets

Mergers & Acquisitions

Special Purpose Acquisition Companies (SPACs)